117 related articles for article (PubMed ID: 36618147)
1. Comparative study of clinical features and vaccination status in Omicron and non-Omicron infected patients during the third wave in Mumbai, India.
Takke A; Zarekar M; Muthuraman V; Ashar A; Patil K; Badhavkar A; Trivedi J; Khargekar N; Madkaikar M; Banerjee A
J Family Med Prim Care; 2022 Oct; 11(10):6135-6142. PubMed ID: 36618147
[TBL] [Abstract][Full Text] [Related]
2. Clinical profile of patients infected with suspected SARS-CoV-2 Omicron variant of concern, Tamil Nadu, India, December 2021-January 2022.
Raju MK; Vivian Thangaraj JW; Selvavinayagam TS; Somasundaram A; Parthipan K; Sivadoss R; Sabarinathan R; Subramaniam S; A Rozario AG; Rani SD; Suganya E; Murhekar MV
Indian J Med Res; 2022 Jan; 155(1):165-170. PubMed ID: 35417991
[TBL] [Abstract][Full Text] [Related]
3. Association Between Vaccination Coverage Disparity and the Dynamics of the COVID-19 Delta and Omicron Waves in the US.
Cuadros DF; Moreno CM; Musuka G; Miller FD; Coule P; MacKinnon NJ
Front Med (Lausanne); 2022; 9():898101. PubMed ID: 35775002
[TBL] [Abstract][Full Text] [Related]
4. A Quick Displacement of the SARS-CoV-2 variant Delta with Omicron: Unprecedented Spike in COVID-19 Cases Associated with Fewer Admissions and Comparable Upper Respiratory Viral Loads.
Fall A; Eldesouki RE; Sachithanandham J; Morris CP; Norton JM; Gaston DC; Forman M; Abdullah O; Gallagher N; Li M; Swanson NJ; Pekosz A; Klein EY; Mostafa HH
medRxiv; 2022 Jan; ():. PubMed ID: 35118480
[TBL] [Abstract][Full Text] [Related]
5. An in-depth appraisal of clinico-biochemical and radiological findings of COVID-19 patients during the COVID-19 pandemic in a dedicated COVID Care Hospital in Eastern India and its outcome in relation to the COVAXIN vaccination status: A 2-year study.
Rao CM; Mohapatra AK; Patnaik AK; Panda PS; Behera PR
J Family Med Prim Care; 2023 May; 12(5):971-978. PubMed ID: 37448914
[TBL] [Abstract][Full Text] [Related]
6. Clinical severity of COVID-19 in patients admitted to hospital during the omicron wave in South Africa: a retrospective observational study.
Jassat W; Abdool Karim SS; Mudara C; Welch R; Ozougwu L; Groome MJ; Govender N; von Gottberg A; Wolter N; Wolmarans M; Rousseau P; ; Blumberg L; Cohen C
Lancet Glob Health; 2022 Jul; 10(7):e961-e969. PubMed ID: 35597249
[TBL] [Abstract][Full Text] [Related]
7. Surveillance of omicron variant in Kangra District of Himachal Pradesh, India during the 3rd disease wave of COVID-19.
Kumar S; Choudhary S; Thakur S; Kumar A; Kumar S
J Infect Dev Ctries; 2023 Apr; 17(4):448-453. PubMed ID: 37159890
[TBL] [Abstract][Full Text] [Related]
8. Hybrid immunity and protection against infection during the Omicron wave in Malta.
Cauchi JP; Dziugyte A; Borg ML; Melillo T; Zahra G; Barbara C; Souness J; Agius S; Calleja N; Gauci C; Vassallo P; Baruch J
Emerg Microbes Infect; 2023 Dec; 12(1):e2156814. PubMed ID: 36510837
[TBL] [Abstract][Full Text] [Related]
9. Maternal and perinatal outcomes of SARS-CoV-2 infection in unvaccinated pregnancies during Delta and Omicron waves.
Birol Ilter P; Prasad S; Mutlu MA; Tekin AB; O'Brien P; von Dadelszen P; Magee LA; Tekin S; Tug N; Kalafat E; Khalil A
Ultrasound Obstet Gynecol; 2022 Jul; 60(1):96-102. PubMed ID: 35441407
[TBL] [Abstract][Full Text] [Related]
10. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
Accorsi EK; Britton A; Fleming-Dutra KE; Smith ZR; Shang N; Derado G; Miller J; Schrag SJ; Verani JR
JAMA; 2022 Feb; 327(7):639-651. PubMed ID: 35060999
[TBL] [Abstract][Full Text] [Related]
11. Epidemiological characteristics of 17 imported patients infected with SARS-CoV-2 Omicron variant.
Liu X; Chen M; Zhou Z; Chen D; Mo J; Liu J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Mar; 47(3):344-351. PubMed ID: 35545327
[TBL] [Abstract][Full Text] [Related]
12. Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: From the first wave to Omicron.
Kawano Y; Patel NJ; Wang X; Cook CE; Vanni KMM; Kowalski EN; Banasiak EP; Qian G; DiIorio M; Hsu TYT; Weinblatt ME; Todd DJ; Wallace ZS; Sparks JA
medRxiv; 2022 Jun; ():. PubMed ID: 35765565
[TBL] [Abstract][Full Text] [Related]
13. Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in tshwane, south africa.
Abdullah F; Myers J; Basu D; Tintinger G; Ueckermann V; Mathebula M; Ramlall R; Spoor S; de Villiers T; Van der Walt Z; Cloete J; Soma-Pillay P; Rheeder P; Paruk F; Engelbrecht A; Lalloo V; Myburg M; Kistan J; van Hougenhouck-Tulleken W; Boswell MT; Gray G; Welch R; Blumberg L; Jassat W
Int J Infect Dis; 2022 Mar; 116():38-42. PubMed ID: 34971823
[TBL] [Abstract][Full Text] [Related]
14. Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland-A multicentre cohort study.
Babouee Flury B; Güsewell S; Egger T; Leal O; Brucher A; Lemmenmeier E; Meier Kleeb D; Möller JC; Rieder P; Rütti M; Schmid HR; Stocker R; Vuichard-Gysin D; Wiggli B; Besold U; McGeer A; Risch L; Friedl A; Schlegel M; Kuster SP; Kahlert CR; Kohler P;
PLoS Med; 2022 Nov; 19(11):e1004125. PubMed ID: 36342956
[TBL] [Abstract][Full Text] [Related]
15. Likelihood of infecting or getting infected with COVID-19 as a function of vaccination status, as investigated with a stochastic model for Aotearoa New Zealand for Delta and Omicron variants.
Watson LM
N Z Med J; 2022 Apr; 135():89-100. PubMed ID: 35728188
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of clinical characteristics of 362 vaccinated or unvaccinated patients infected by novel coronavirus Omicron variant].
Feng Q; Wang Z; Yu H; Shi L; Xu L
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 May; 34(5):459-464. PubMed ID: 35728844
[TBL] [Abstract][Full Text] [Related]
17. Nationwide Effectiveness of First and Second SARS-CoV2 Booster Vaccines During the Delta and Omicron Pandemic Waves in Hungary (HUN-VE 2 Study).
Kiss Z; Wittmann I; Polivka L; Surján G; Surján O; Barcza Z; Molnár GA; Nagy D; Müller V; Bogos K; Nagy P; Kenessey I; Wéber A; Pálosi M; Szlávik J; Schaff Z; Szekanecz Z; Müller C; Kásler M; Vokó Z
Front Immunol; 2022; 13():905585. PubMed ID: 35812442
[TBL] [Abstract][Full Text] [Related]
18. Humoral Response in Hemodialysis Patients Following COVID-19 Vaccination and Breakthrough Infections during Delta and Omicron Variant Predominance.
Chinnadurai R; Wu HHL; Cox E; Moore J; Clough T; Lamerton E; Donne R; O'Riordan E; Poulikakos D
Vaccines (Basel); 2022 Mar; 10(4):. PubMed ID: 35455248
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 B.1.1.529 (Omicron) Variant Causes an Unprecedented Surge in Children Hospitalizations and Distinct Clinical Presentation Compared to the SARS-CoV-2 B.1.617.2 (Delta) Variant.
Taytard J; Prevost B; Schnuriger A; Aubertin G; Berdah L; Bitton L; Dupond-Athenor A; Thouvenin G; Nathan N; Corvol H
Front Pediatr; 2022; 10():932170. PubMed ID: 35832582
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022.
Thompson MG; Natarajan K; Irving SA; Rowley EA; Griggs EP; Gaglani M; Klein NP; Grannis SJ; DeSilva MB; Stenehjem E; Reese SE; Dickerson M; Naleway AL; Han J; Konatham D; McEvoy C; Rao S; Dixon BE; Dascomb K; Lewis N; Levy ME; Patel P; Liao IC; Kharbanda AB; Barron MA; Fadel WF; Grisel N; Goddard K; Yang DH; Wondimu MH; Murthy K; Valvi NR; Arndorfer J; Fireman B; Dunne MM; Embi P; Azziz-Baumgartner E; Zerbo O; Bozio CH; Reynolds S; Ferdinands J; Williams J; Link-Gelles R; Schrag SJ; Verani JR; Ball S; Ong TC
MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):139-145. PubMed ID: 35085224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
